156 related articles for article (PubMed ID: 15498520)
1. The use of proteomics for the assessment of clinical samples in research.
Aldred S; Grant MM; Griffiths HR
Clin Biochem; 2004 Nov; 37(11):943-52. PubMed ID: 15498520
[TBL] [Abstract][Full Text] [Related]
2. Advances in clinical cancer proteomics: SELDI-ToF-mass spectrometry and biomarker discovery.
Seibert V; Ebert MP; Buschmann T
Brief Funct Genomic Proteomic; 2005 May; 4(1):16-26. PubMed ID: 15975261
[TBL] [Abstract][Full Text] [Related]
3. [Mass spectrometry and clinical proteomics].
Baudin B
Ann Biol Clin (Paris); 2015; 73(1):39-48. PubMed ID: 25582721
[TBL] [Abstract][Full Text] [Related]
4. Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging.
Smith A; Galli M; Piga I; Denti V; Stella M; Chinello C; Fusco N; Leni D; Manzoni M; Roversi G; Garancini M; Pincelli AI; Cimino V; Capitoli G; Magni F; Pagni F
J Proteomics; 2019 Jan; 191():114-123. PubMed ID: 29581064
[TBL] [Abstract][Full Text] [Related]
5. Identification of parotid salivary biomarkers in Sjogren's syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis.
Ryu OH; Atkinson JC; Hoehn GT; Illei GG; Hart TC
Rheumatology (Oxford); 2006 Sep; 45(9):1077-86. PubMed ID: 16522680
[TBL] [Abstract][Full Text] [Related]
6. [Advances in plant proteomics--I. Key techniques of proteome].
Ruan SL; Ma HS; Wan SH; Xin Y; Qian LH; Tong JX; Wang J
Yi Chuan; 2006 Nov; 28(11):1472-86. PubMed ID: 17098721
[TBL] [Abstract][Full Text] [Related]
7. MALDI mass spectrometry in prostate cancer biomarker discovery.
Flatley B; Malone P; Cramer R
Biochim Biophys Acta; 2014 May; 1844(5):940-9. PubMed ID: 23831156
[TBL] [Abstract][Full Text] [Related]
8. [Clinical proteomics in laboratory medicine].
Nomura F
Rinsho Byori; 2006 Apr; 54(4):413-20. PubMed ID: 16722462
[TBL] [Abstract][Full Text] [Related]
9. Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways.
Sun S; Lee NP; Poon RT; Fan ST; He QY; Lau GK; Luk JM
Liver Int; 2007 Oct; 27(8):1021-38. PubMed ID: 17845530
[TBL] [Abstract][Full Text] [Related]
10. Physiological proteomics: cells, organs, biological fluids, and biomarkers.
Blake CA
Exp Biol Med (Maywood); 2005 Dec; 230(11):785-6. PubMed ID: 16339741
[TBL] [Abstract][Full Text] [Related]
11. Application of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) in Alzheimer's disease.
Grela A; Turek A; Piekoszewski W
Clin Chem Lab Med; 2012 Feb; 50(8):1297-304. PubMed ID: 22868793
[TBL] [Abstract][Full Text] [Related]
12. Comparative proteomic analyses of the yeast Saccharomyces cerevisiae KNU5377 strain against menadione-induced oxidative stress.
Kim I; Yun H; Jin I
J Microbiol Biotechnol; 2007 Feb; 17(2):207-17. PubMed ID: 18051751
[TBL] [Abstract][Full Text] [Related]
13. Proteomics: techniques and applications in cancer research.
Schramm A; Apostolov O; Sitek B; Pfeiffer K; Stühler K; Meyer HE; Havers W; Eggert A
Klin Padiatr; 2003; 215(6):293-7. PubMed ID: 14677091
[TBL] [Abstract][Full Text] [Related]
14. Opportunities and limitations of SELDI-TOF-MS in biomedical research: practical advices.
Poon TC
Expert Rev Proteomics; 2007 Feb; 4(1):51-65. PubMed ID: 17288515
[TBL] [Abstract][Full Text] [Related]
15. An integrated approach to identifying chemically induced posttranslational modifications using comparative MALDI-MS and targeted HPLC-ESI-MS/MS.
Person MD; Monks TJ; Lau SS
Chem Res Toxicol; 2003 May; 16(5):598-608. PubMed ID: 12755589
[TBL] [Abstract][Full Text] [Related]
16. Proteomics in mammary cancer research.
Fink-Retter A; Czerwenka K; Gschwantler-Kaulich D; Hudelist G; Pischinger K; Manavi M; Kubista E; Singer CF
Eur J Gynaecol Oncol; 2009; 30(6):635-9. PubMed ID: 20099493
[TBL] [Abstract][Full Text] [Related]
17. Development of an integrated approach for evaluation of 2-D gel image analysis: impact of multiple proteins in single spots on comparative proteomics in conventional 2-D gel/MALDI workflow.
Yang Y; Thannhauser TW; Li L; Zhang S
Electrophoresis; 2007 Jun; 28(12):2080-94. PubMed ID: 17486657
[TBL] [Abstract][Full Text] [Related]
18. Trypsin catalyzed 16O-to-18O exchange for comparative proteomics: tandem mass spectrometry comparison using MALDI-TOF, ESI-QTOF, and ESI-ion trap mass spectrometers.
Heller M; Mattou H; Menzel C; Yao X
J Am Soc Mass Spectrom; 2003 Jul; 14(7):704-18. PubMed ID: 12837592
[TBL] [Abstract][Full Text] [Related]
19. Direct-tissue SELDI-TOF mass spectrometry analysis: a new application for clinical proteomics.
Bouamrani A; Ternier J; Ratel D; Benabid AL; Issartel JP; Brambilla E; Berger F
Clin Chem; 2006 Nov; 52(11):2103-6. PubMed ID: 16990423
[TBL] [Abstract][Full Text] [Related]
20. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
